These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevention and nondialytic treatment of acute renal failure. Lameire NH; De Vriese AS; Vanholder R Curr Opin Crit Care; 2003 Dec; 9(6):481-90. PubMed ID: 14639067 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Yasuda H; Yuen PS; Hu X; Zhou H; Star RA Kidney Int; 2006 May; 69(9):1535-42. PubMed ID: 16557230 [TBL] [Abstract][Full Text] [Related]
9. Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis. Ishikawa K; Calzavacca P; Bellomo R; Bailey M; May CN Crit Care Med; 2012 Aug; 40(8):2368-75. PubMed ID: 22622397 [TBL] [Abstract][Full Text] [Related]
10. Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Esmon CT Crit Care Med; 2001 Jul; 29(7 Suppl):S48-51; discussion 51-2. PubMed ID: 11445734 [TBL] [Abstract][Full Text] [Related]
11. Effects of anticoagulant strategies on activation of inflammation and coagulation. Feistritzer C; Wiedermann CJ Expert Opin Biol Ther; 2007 Jun; 7(6):855-70. PubMed ID: 17555371 [TBL] [Abstract][Full Text] [Related]
12. [Severe sepsis as a cause of acute renal failure]. Díaz de León M; Moreno SA; González Díaz DJ; Briones GJ Nefrologia; 2006; 26(4):439-44. PubMed ID: 17058855 [TBL] [Abstract][Full Text] [Related]
13. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Knotek M; Rogachev B; Wang W; Ecder T; Melnikov V; Gengaro PE; Esson M; Edelstein CL; Dinarello CA; Schrier RW Kidney Int; 2001 Jun; 59(6):2243-9. PubMed ID: 11380827 [TBL] [Abstract][Full Text] [Related]
14. Role of endothelin and tumour necrosis factor in the renal response to sepsis. Kohan DE Nephrol Dial Transplant; 1994; 9 Suppl 4():73-7. PubMed ID: 7800273 [TBL] [Abstract][Full Text] [Related]
15. Renal rescue therapy in early stage of severe sepsis: a case study approach. Zahorec R; Setvak D; Cintula D; Belovicova C; Blaskova A Bratisl Lek Listy; 2004; 105(10-11):345-52. PubMed ID: 15658572 [TBL] [Abstract][Full Text] [Related]
16. Renal cell apoptosis and new treatment options in sepsis-induced acute kidney injury. Koçkara A; Kayataş M Ren Fail; 2013; 35(2):291-4. PubMed ID: 23181751 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience. de Jonge E; van der Poll T; Kesecioglu J; Levi M Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690 [TBL] [Abstract][Full Text] [Related]
18. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. De Kimpe SJ; Thiemermann C; Vane JR Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795 [TBL] [Abstract][Full Text] [Related]
19. Sepsis and inflammation: impact on acute kidney injury. Dirkes S Nephrol Nurs J; 2013; 40(2):125-32; quiz 133. PubMed ID: 23767336 [TBL] [Abstract][Full Text] [Related]
20. Coagulation inhibitor replacement during sepsis: useless? Hoffman JN; Faist E Crit Care Med; 2000 Sep; 28(9 Suppl):S74-6. PubMed ID: 11007203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]